Characteristics of infants at trial entry (data are median (range) or number (%))
| All infants | Surviving infants | ||||||
|---|---|---|---|---|---|---|---|
| Control group (n=122) | Experimental group (n=123) | Control group (n=106) | Experimental group (n=104) | ||||
| Birthweight (g) | 1423 (580-5250) | 1426 (452-4400) | 1525 (640-4200) | 1531 (592-4400) | |||
| Birth length (cm) | 40 (30-57) | 40 (29-55) | 41 (32-57) | 41 (30-55) | |||
| Gestation (weeks) | 31 (23-42) | 30 (25-42) | 31 (25-42) | 31 (25-42) | |||
| Gender (M/F) | 62/60 (51%:49%)2-150 | 79/44 (64%:36%)2-150 | 52:54 (49%:51%)2-150 | 67:37 (64%:36%)2-150 | |||
| Antenatal steroids | 37 (30%) | 44 (36%) | 22 (21%) | 30 (29%) | |||
| Initial Crs successful | 94 (77%) | 102 (83%) | 82 (77%) | 86 (83%) | |||
| Crs (ml/cm H2O/m) | 1.5 (0.5-7.9) | 1.4 (0.5-5.6) | 1.5 (0.5-7.9) | 1.5 (0.6-5.6) | |||
| Crs (ml/cm H2O/kg) | 0.4 (0.11-1.18) | 0.36 (0.15-1.35) | 0.4 (0.11-1.18) | 0.38 (0.15-1.35) | |||
| Inborn | 106 (87%) | 110 (89%) | 94 (89%) | 96 (92%) | |||
| Delivery mode | |||||||
| Vaginal | 63 (52%) | 56 (46%) | 52 (49%) | 47 (45%) | |||
| Caesarean | 59 (48%) | 67 (54%) | 54 (51%) | 57 (55%) | |||
| Singleton | 99 (81%) | 99 (80%) | 86 (81%) | 83 (80%) | |||
| Apgar at 1 minute | 5 (0-9) | 5 (0-9) | 5 (0-9) | 5 (0-9) | |||
| Apgar at 5 minutes | 8 (0-9) | 8 (1-9) | 8 (0-9) | 8 (1-9) | |||
↵2-150 Denotes significant difference between study groups (p < 0.05).